Kelley Lynne E 4
4 · HISTOGENICS CORP · Filed Aug 1, 2018
Insider Transaction Report
Form 4
HISTOGENICS CORPHSGX
Kelley Lynne E
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-07-31+200,000→ 200,000 totalExercise: $2.21Exp: 2028-07-30→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option vests over four (4) years of service following August 6, 2018, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service and the balance vesting in thirty-six (36) equal monthly installments thereafter.